Strides Pharma Science Limited (Strides) has achieved a significant milestone in the pharmaceutical industry with the United States Food & Drug Administration (USFDA) approval of Pregabalin capsules, spanning dosages from 25 mg to 300 mg. This approval was granted to Strides Pharma Global Pte. Limited, Singapore, a step-down wholly owned subsidiary of Strides, marking a […]
Zydus Lifesciences (formerly known as Cadila Healthcare) has secured final approvals from the US Food and Drug Administration (FDA) for Silodosin Capsules, 4 mg and 8 mg and Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg. The two generic drugs will be manufactured by […]
Marksans Pharma has secured final approval for its abbreviated new drug application (ANDA) for Pregabalin Capsules from the US Food & Drugs Administration (FDA). The approval is for the 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg strengths of Pregabalin Capsules. It is indicated in relieving pain […]
Rising Pharmaceuticals has launched a generic version of Lyrica, (pregabalin) Capsules in the US, in all eight commercially available strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg. According to IMS Health, Pregabalin Capsules had sales of around $5.5bn in the US for the 12 […]